Experimental ocular toxoplasmosis in naive and primed rabbits

Ophthalmologica

Volumn 212, Issue 2, 1998, Pages 136-141

  Garweg, Justus G ^a   Kuenzli, Hans ^a   Boehnke, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Disease reactivation; Experimental ocular toxoplasmosis; Rabbit model; Retinal detachment; Survival

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; GENTAMICIN;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHORIORETINITIS; DISEASE COURSE; ENDOPHTHALMITIS; EXPERIMENTAL INFECTION; IMMUNE STATUS; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PATHOPHYSIOLOGY; RABBIT; RETINA DETACHMENT; SURVIVAL RATE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; CELL COUNT; CHORIORETINITIS; CLINDAMYCIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; MALE; RABBITS; RETINAL DETACHMENT; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; VITREOUS BODY;

EID: 0031907931     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027293     Document Type: Article

References (37)

1. Johnson LV: Use of neutralizing antibody test in the diagnosis of human toxoplasmic choroiditis. Arch Ophthalmol 1946;36:677-684.
2. Wilder HC: Toxoplasma chorioretinitis in adults. Arch Ophthalmol 1952;48:127-136.
3. Tabbara KF: Toxoplasmosis; in Duane (ed): Ocular Diseases. Churchill Lipinscott Inc., 1990, vol 4, chapt 46, pp 1-23.
4. Desmonts G: Definite diagnosis of ocular toxoplasmosis. Arch Ophthalmol 1966;76:839-851.
5. Kijlstra A, Luyendijk L, Baarsma GS, Rothova A, Schweitzer CM, Timmermann Z, et al: Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol 1989;13: 383-386.
6. Rothova A: Ocular involvement in toxoplasmosis. Br J Ophthalmol 1993;77:371-377.
7. Darcy F, Zenner L: Experimental models of toxoplasmosis. Res Immunol 1993;144:16-23.
8. Culbertson WW, Tabbara KF, O'Connor GR: Experimental ocular toxoplasmosis in primates. Arch Ophthalmol 1982;100:321-323.
9. Winser J, Verlinde JD, van Thiel PH, Davel J, van der Elst P: Isolation of Toxoplasma from cerebrospinal fluid of a living child in Holland. Proc Soc Exp Biol Med 1948;67:292-294.
10. Gross U, Roos T, Appoldt D, Heesemann J: Improved serological diagnosis of Toxoplasma gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against p-30 by using the immunoblot technique. J Clin Microbiol 1992;30:1436-1441.
11. Sabin AB: Toxoplasmic encephalitis in children. JAMA 1941;116:801-807.
12. Newman PE, Ghosheh R, Tabbara KF, O'Connor GR, Stern W: The role of hypersensitivity reactions to Toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates. Am J Ophthalmol 1982;94:159-164.
13. Jacobs L: Propagation, morphology, and biology of Toxoplasma. Ann NY Acad Sci 1956;64: 154-179.
14. Olisa EG, Herson J, Headings VE, Poindexter HA: Toxoplasma gondii: Survival time and variability in mouse host strains. Exp Parasitol 1977;41:307-313.
15. Fuji H, Kamiyama T, Hagiwara T: Species and strain differences in sensitivity to Toxoplasma infection among laboratory rodents. Jpn J Med Sci Biol 1983;36:343-346.
16. Eyles DE, Coleman N: Relationship between size of inoculum to time of death in mice infected with Toxoplasma gondii. J Parasitol 1956;42: 272-275.
17. Huldt G: Experimental toxoplasmosis: Effect of inoculation of Toxoplasma in seropositive rabbits. Acta Pathol Microbiol Scand 1966;68: 592-604.
18. Webb RM, Tabbara KF, O'Connor GR: Retinal vasculitis in ocular toxoplasmosis in nonhuman primates. Retina 1984;4:182-188.
19. Friedrich R, Müller WA: Der Einfluss einersubretinalen Injektion von Toxoplasma gondii auf den Serumantikörperspiegel in einem Kaninchenmodell der Augentoxoplasmose. Angew Parasitol 1989;30:15-17.
20. Hogan MJ: Ocular Toxoplasmosis. New York, Columbia University Press, 1951.
21. Cited from Frenkel JK: Ocular lesions in hamsters with chronic Toxoplasma and Besnoitia infection. Am J Ophthalmol 1955;39:203-225.
22. Frenkel JK: Host, strain and treatment variation as factors in the pathogenesis of toxoplasmosis. Am J Trop Med Hyg 1953;2:390-415.
23. Jacobs L, Hart WM, Ryan RW, Cook MK: The production of experimental ocular toxoplasmosis in rabbits. Acta VII Cone Ophthalmol 1946-1953, 1954.
24. Cited from Jacobs L, Melton ML, Kaufman HE: Treatment of Experimental Ocular Toxoplasmosis. Arch Ophthalmol 1964;71: 145-152.
25. Beverley JK, Beattie CP, Fry BA: Experimental toxoplasmosis of the uveal tract. Br J Ophthalmol 1954;38:489-496.
26. Beverley JK: Experimental ocular toxoplasmosis. Surv Ophthalmol 1961;6:897-905.
27. Vogel AW: Experimental fundal lesions: A method and observations. Arch Ophthalmol 1954;51:535-548.
28. Nozik RA, O'Connor GR: Experimental ocular toxoplasmic retinochoroiditis. Arch Ophthalmol 1968;79:485-489.
29. Wilson CB, Remington JS: Activity of human blood leucocytes against Toxoplasma gondii. J Infect Dis 1979;140:890-895.
30. Friedrich R, Simon HU, Müller WA, Sych FJ: Ocular toxoplasmosis: The role of cellular immune defense in the development of recurrences. Ger J Ophthalmol 1992;1:54-57.
31. Rollins DF, Tabbara KF, O'Connor GR, Araujo FG, Remington SG: Detection of toxoplasmal antigen and antibody in ocular fluids in experimental oculartoxoplasmosis. Arch Ophthalmol 1983;101:455-457.
32. Hogan MJ, Zweigart PA, Lewis A: Persistance of Toxoplasma gondii in ocular tissues. Am J Ophthalmol 1956;42:84-89.
33. Kaufman HE: The effect of corticosteroids on experimental ocular toxoplasmosis. Am J Ophthalmol 1960;50:919-925.
34. Streilein JW: Immune regulation and the eye: A dangerous compromise. FASEB J 1987;1:199-208.
35. Frenkel JK, Jacobs L: Ocular toxoplasmosis: Pathogenesis, diagnosis, and treatment. Arch Ophthalmol 1958;59:260-279.
36. Nozik RA, O'Connor GR: Studies on experimental ocular toxoplasmosis in the rabbit. III. Recurrent inflammation stimulated by systemic administration of antilymphocyte serum and normal horse serum. Arch Ophthalmol 1971; 85:718-722.
37. Holland GN, O'Connor GR, Diaz RP, Minasi P, Wara WM: Ocular toxoplasmosis in immunosuppressed nonhuman primates. Invest Ophthalmol Vis Sci 1988;29:835-842.